These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 18192092

  • 1. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M, Roehrl MH, Basar E, Wang JY.
    Vaccine; 2008 Feb 13; 26(7):947-55. PubMed ID: 18192092
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD, Wilder JA, Mega WM, Hutt JA, Kuehl PJ, Valderas MW, Chew LL, Liang BC, Squires CH.
    PLoS One; 2015 Feb 13; 10(7):e0130952. PubMed ID: 26207820
    [Abstract] [Full Text] [Related]

  • 7. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD.
    Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781
    [Abstract] [Full Text] [Related]

  • 8. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 03; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M, Hasannia S, Salmanian AH, Shahryar Arab S, Shali A, Alizadeh GA, Hajizadeh A, Khafri A, Mohseni A.
    Immunopharmacol Immunotoxicol; 2019 Feb 03; 41(1):25-31. PubMed ID: 30621469
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
    Abboud N, Casadevall A.
    Clin Vaccine Immunol; 2008 Jul 03; 15(7):1115-23. PubMed ID: 18480236
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC, An HJ, Yu YZ, Xu Q.
    Immunol Lett; 2015 Feb 01; 163(2):206-13. PubMed ID: 25102364
    [Abstract] [Full Text] [Related]

  • 16. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J, Grover S, Rahi A, Chaudhary P, Rajwanshi R, Sarin NB, Bhatnagar R.
    J Biotechnol; 2014 Apr 20; 176():1-10. PubMed ID: 24548460
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
    Sloat BR, Cui Z.
    Pharm Res; 2006 Jun 20; 23(6):1217-26. PubMed ID: 16718616
    [Abstract] [Full Text] [Related]

  • 20. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Spooner CE, Chen H, Ballard J, James JA, Farris AD.
    Clin Vaccine Immunol; 2017 Nov 20; 24(11):. PubMed ID: 28877928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.